Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Tain, You Lin ^a   Huang, Li Tung ^a   Hsu, Chien Ning ^a,b   Lee, Chien Te ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; GENE EXPRESSION; NITRIC OXIDE; PLASMAS; POSITIVE IONS; RATS;

ANGIOTENSIN CONVERTING ENZYME 2; ASYMMETRIC DIMETHYLARGININE; CALORIC RESTRICTION; NEXT-GENERATION SEQUENCING; NITRIC OXIDE SYNTHASE INHIBITORS; PRORENIN RECEPTORS; PROTECTIVE EFFECTS; RENIN-ANGIOTENSIN SYSTEM;

HORMONES;

ARGININE; MELATONIN; N,N-DIMETHYLARGININE; NITRIC OXIDE;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CALORIC RESTRICTION; DIET THERAPY; DRUG EFFECTS; FEMALE; HYPERTENSION; IN VITRO STUDY; KIDNEY; MALE; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE; CALORIC RESTRICTION; FEMALE; HYPERTENSION; IN VITRO TECHNIQUES; KIDNEY; MALE; MELATONIN; NITRIC OXIDE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901356705     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/283180     Document Type: Article

References (28)

1. Ojeda N. B., Grigore D., Alexander B. T., Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension 2008 52 1 44 50 2-s2.0-46449111527 10.1161/HYPERTENSIONAHA.107. 092890
2. Bagby S. P., Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. Journal of Nutrition 2007 137 4 1066 1072 2-s2.0-34247099839 (Pubitemid 46596912)
3. McMillen I. C., Robinson J. S., Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 2005 85 2 571 633 2-s2.0-15544369982 10.1152/physrev.00053.2003 (Pubitemid 40404637)
4. Alwasel S. H., Ashton N., Prenatal programming of renal sodium handling in the rat. Clinical Science 2009 117 2 75 84 2-s2.0-67749137655 10.1042/CS20080294
5. Vehaskari V. M., Stewart T., Lafont D., Soyez C., Seth D., Manning J., Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. The American Journal of Physiology-Renal Physiology 2004 287 2 F262 F267 2-s2.0-3242733152 10.1152/ajprenal.00055.2004 (Pubitemid 38943942)
6. Dennery P. A., Oxidative stress in development: nature or nurture? Free Radical Biology and Medicine 2010 49 7 1147 1151 2-s2.0-77956176210 10.1016/j.freeradbiomed.2010.07.011
7. Wilcox C. S., Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005 289 4 R913 R935 2-s2.0-25844513144 10.1152/ajpregu.00250.2005 (Pubitemid 41397037)
8. Baylis C., Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nature Clinical Practice Nephrology 2006 2 4 209 220 2-s2.0-33646886617 10.1038/ncpneph0143 (Pubitemid 43787287)
9. Tain Y.-L., Huang L.-T., Asymmetric dimethylarginine: clinical applications in pediatric medicine. Journal of the Formosan Medical Association 2011 110 2 70 77 2-s2.0-79955628675 10.1016/S0929-6646(11)60012-0
10. Tain Y.-L., Hsieh C.-S., Lin I.-C., Chen C.-C., Sheen J.-M., Huang L.-T., Effects of maternal l-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 2010 23 1 34 41 2-s2.0-77952240266 10.1016/j.niox.2010.03.005
11. Tain Y. L., Lee W. C., Hsu C. N., Lee W. C., Huang L. T., Lee C. T., Lin C. Y., Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. PLoS ONE 2013 8 2 e55420
12. Chen S., Bellew C., Yao X., Stefkova J., Dipp S., Saifudeen Z., Bachvarov D., El-Dahr S. S., Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. The Journal of Biological Chemistry 2011 286 37 32775 32789 2-s2.0-80052753687 10.1074/jbc.M111.248278
13. Song R., Van Buren T., Yosypiv I. V., Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis. Pediatric Research 2010 67 6 573 578 2-s2.0-77952516979 10.1203/PDR.0b013e3181da477c
14. Galano A., Tan D. X., Reiter R. J., On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. Journal of Pineal Research 2013 54 3 245 257 10.1111/jpi.12010
15. Tain Y.-L., Huang L.-T., Lin I.-C., Lau Y.-T., Lin C.-Y., Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. Journal of Pineal Research 2010 49 4 390 398 2-s2.0-78349275306 10.1111/j.1600-079X.2010.00806.x
16. Korkmaz A., Rosales-Corral S., Reiter R. J., Gene regulation by melatonin linked to epigenetic phenomena. Gene 2012 503 1 1 11 10.1016/j.gene.2012.04.040
17. Jung-Hynes B., Reiter R. J., Ahmad N., Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. Journal of Pineal Research 2010 48 1 9 19 2-s2.0-71549154751 10.1111/j.1600-079X.2009.00729.x
18. Tain Y.-L., Baylis C., Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney International 2007 72 7 886 889 2-s2.0-34648820108 10.1038/sj.ki.5002446 (Pubitemid 47462078)
19. Mortazavi A., Williams B. A., McCue K., Schaeffer L., Wold B., Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 2008 5 7 621 628 2-s2.0-46249106990 10.1038/nmeth.1226 (Pubitemid 351911867)
20. Okatani Y., Wakatsuki A., Kaneda C., Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. Journal of Pineal Research 2000 28 2 89 96 2-s2.0-0033998384 10.1034/j.1600-079X.2001. 280204.x (Pubitemid 30125173)
21. Watanabe K., Wakatsuki A., Shinohara K., Ikenoue N., Yokota K., Fukaya T., Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. Journal of Pineal Research 2004 37 4 276 280 2-s2.0-7644221985 10.1111/j.1600-079X.2004.00167.x (Pubitemid 39457049)
22. Bogdarina I., Welham S., King P. J., Burns S. P., Clark A. J. L., Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research 2007 100 4 520 526 2-s2.0-33947517327 10.1161/01.RES.0000258855.60637.58 (Pubitemid 46673261)
23. Goyal R., Goyal D., Leitzke A., Gheorghe C. P., Longo L. D., Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reproductive Sciences 2010 17 3 227 238 2-s2.0-77949478630 10.1177/1933719109351935
24. Feng Y., Xia H., Santos R. A., Speth R., Lazartigues E., Angiotensin-converting enzyme 2: a new target for neurogenic hypertension. Experimental Physiology 2010 95 5 601 606 2-s2.0-77951183011 10.1113/expphysiol.2009.047407
25. Sharma R., Ottenhof T., Rzeczkowska P. A., Niles L. P., Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. Journal of Pineal Research 2008 45 3 277 284 2-s2.0-51649128880 10.1111/j.1600-079X.2008.00587.x
26. Singh H. J., Keah L. S., Kumar A., Sirajudeen K. N. S., Adverse effects of melatonin on rat pups of Wistar-Kyoto dams receiving melatonin supplementation during pregnancy. Experimental and Toxicologic Pathology 2012 64 7-8 751 752 2-s2.0-79951947346 10.1016/j.etp.2011.01.011
27. Dickinson H., Walker D. W., Wintour E. M., Moritz K., Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007 292 1 R453 R461 2-s2.0-33846259288 10.1152/ajpregu.00481.2006 (Pubitemid 46091602)
28. Abdel-Hakeem A. K., Henry T. Q., Magee T. R., Desai M., Ross M. G., Mansano R. Z., Torday J. S., Nast C. C., Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. The American Journal of Obstetrics and Gynecology 2008 199 3 252.e1 252.e7 2-s2.0-50349100544 10.1016/j.ajog.2008.05.018